aluates Reports

$ 0.0

Automative

Global Extended-release Medication Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-33J14051

Global Extended release Medication Market Research Report 2023

BUY CHAPTERS

Global Extended-release Medication Market Research Report 2025

Code: QYRE-Auto-33J14051

Report

May 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Johnson & Johnson

Takeda

Astrazeneca plc

AbbVie

Pfizer Inc

Collegium Pharmaceutical, Inc.

Endo Pharmaceuticals

Shanghai Shyndec Pharmaceutical

Zhuhai Rundu Pharmaceutical

China Res Double-Crane

Novartis

Sanofi

Extended-release Medication Market Size

The global market for Extended-release Medication was valued at US$ 39890 million in the year 2024 and is projected to reach a revised size of US$ 61970 million by 2031, growing at a CAGR of 6.6% during the forecast period.

Extended-release Medication Market

Extended-release Medication refers to pharmaceutical drugs designed to release their active ingredients gradually over an extended period within the body. This controlled-release mechanism allows for a more stable and prolonged therapeutic effect, reducing the need for frequent dosing and minimizing potential side effects. Extended-release medications are commonly used for treating chronic conditions like hypertension, diabetes, and pain management.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Extended-release Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extended-release Medication.

The Extended-release Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Extended-release Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Extended-release Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Extended-release Medication Market Report

Report Metric	Details
Report Name	Extended-release Medication Market
Accounted market size in year	US$ 39890 million
Forecasted market size in 2031	US$ 61970 million
CAGR	6.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Original Medication Generic Medication
Segment by Application	Hospital Drugstore Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, Pfizer, Collegium Pharmaceutical, Inc, Endo Pharmaceuticals, Shanghai Shyndec Pharmaceutical, Zhuhai Rundu Pharmaceutical, China Res Double-Crane
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extended-release Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Extended-release Medication Market growing?

Ans: The Extended-release Medication Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the Extended-release Medication Market size in 2031?

Ans: The Extended-release Medication Market size in 2031 will be US$ 61970 million.

Who are the main players in the Extended-release Medication Market report?

Ans: The main players in the Extended-release Medication Market are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, Pfizer, Collegium Pharmaceutical, Inc, Endo Pharmaceuticals, Shanghai Shyndec Pharmaceutical, Zhuhai Rundu Pharmaceutical, China Res Double-Crane

What are the Application segmentation covered in the Extended-release Medication Market report?

Ans: The Applications covered in the Extended-release Medication Market report are Hospital, Drugstore, Other

What are the Type segmentation covered in the Extended-release Medication Market report?

Ans: The Types covered in the Extended-release Medication Market report are Original Medication, Generic Medication

Recommended Reports

Chronic Disease Drugs

Pain & Sleep Relief

Pharmaceutical Market Trends

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Extended-release Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Original Medication

1.2.3 Generic Medication

1.3 Market by Application

1.3.1 Global Extended-release Medication Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Drugstore

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Extended-release Medication Market Perspective (2020-2031)

2.2 Global Extended-release Medication Growth Trends by Region

2.2.1 Global Extended-release Medication Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Extended-release Medication Historic Market Size by Region (2020-2025)

2.2.3 Extended-release Medication Forecasted Market Size by Region (2026-2031)

2.3 Extended-release Medication Market Dynamics

2.3.1 Extended-release Medication Industry Trends

2.3.2 Extended-release Medication Market Drivers

2.3.3 Extended-release Medication Market Challenges

2.3.4 Extended-release Medication Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Extended-release Medication Players by Revenue

3.1.1 Global Top Extended-release Medication Players by Revenue (2020-2025)

3.1.2 Global Extended-release Medication Revenue Market Share by Players (2020-2025)

3.2 Global Extended-release Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Extended-release Medication Revenue

3.4 Global Extended-release Medication Market Concentration Ratio

3.4.1 Global Extended-release Medication Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Extended-release Medication Revenue in 2024

3.5 Global Key Players of Extended-release Medication Head office and Area Served

3.6 Global Key Players of Extended-release Medication, Product and Application

3.7 Global Key Players of Extended-release Medication, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Extended-release Medication Breakdown Data by Type

4.1 Global Extended-release Medication Historic Market Size by Type (2020-2025)

4.2 Global Extended-release Medication Forecasted Market Size by Type (2026-2031)

5 Extended-release Medication Breakdown Data by Application

5.1 Global Extended-release Medication Historic Market Size by Application (2020-2025)

5.2 Global Extended-release Medication Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Extended-release Medication Market Size (2020-2031)

6.2 North America Extended-release Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Extended-release Medication Market Size by Country (2020-2025)

6.4 North America Extended-release Medication Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Extended-release Medication Market Size (2020-2031)

7.2 Europe Extended-release Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Extended-release Medication Market Size by Country (2020-2025)

7.4 Europe Extended-release Medication Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Extended-release Medication Market Size (2020-2031)

8.2 Asia-Pacific Extended-release Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Extended-release Medication Market Size by Region (2020-2025)

8.4 Asia-Pacific Extended-release Medication Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Extended-release Medication Market Size (2020-2031)

9.2 Latin America Extended-release Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Extended-release Medication Market Size by Country (2020-2025)

9.4 Latin America Extended-release Medication Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Extended-release Medication Market Size (2020-2031)

10.2 Middle East & Africa Extended-release Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Extended-release Medication Market Size by Country (2020-2025)

10.4 Middle East & Africa Extended-release Medication Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Extended-release Medication Introduction

11.1.4 Sanofi Revenue in Extended-release Medication Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Extended-release Medication Introduction

11.2.4 Novartis Revenue in Extended-release Medication Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Extended-release Medication Introduction

11.3.4 Bayer Revenue in Extended-release Medication Business (2020-2025)

11.3.5 Bayer Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Extended-release Medication Introduction

11.4.4 Johnson & Johnson Revenue in Extended-release Medication Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Takeda

11.5.1 Takeda Company Details

11.5.2 Takeda Business Overview

11.5.3 Takeda Extended-release Medication Introduction

11.5.4 Takeda Revenue in Extended-release Medication Business (2020-2025)

11.5.5 Takeda Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Extended-release Medication Introduction

11.6.4 AstraZeneca Revenue in Extended-release Medication Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Details

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Extended-release Medication Introduction

11.7.4 AbbVie Revenue in Extended-release Medication Business (2020-2025)

11.7.5 AbbVie Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Extended-release Medication Introduction

11.8.4 Pfizer Revenue in Extended-release Medication Business (2020-2025)

11.8.5 Pfizer Recent Development

11.9 Collegium Pharmaceutical, Inc

11.9.1 Collegium Pharmaceutical, Inc Company Details

11.9.2 Collegium Pharmaceutical, Inc Business Overview

11.9.3 Collegium Pharmaceutical, Inc Extended-release Medication Introduction

11.9.4 Collegium Pharmaceutical, Inc Revenue in Extended-release Medication Business (2020-2025)

11.9.5 Collegium Pharmaceutical, Inc Recent Development

11.10 Endo Pharmaceuticals

11.10.1 Endo Pharmaceuticals Company Details

11.10.2 Endo Pharmaceuticals Business Overview

11.10.3 Endo Pharmaceuticals Extended-release Medication Introduction

11.10.4 Endo Pharmaceuticals Revenue in Extended-release Medication Business (2020-2025)

11.10.5 Endo Pharmaceuticals Recent Development

11.11 Shanghai Shyndec Pharmaceutical

11.11.1 Shanghai Shyndec Pharmaceutical Company Details

11.11.2 Shanghai Shyndec Pharmaceutical Business Overview

11.11.3 Shanghai Shyndec Pharmaceutical Extended-release Medication Introduction

11.11.4 Shanghai Shyndec Pharmaceutical Revenue in Extended-release Medication Business (2020-2025)

11.11.5 Shanghai Shyndec Pharmaceutical Recent Development

11.12 Zhuhai Rundu Pharmaceutical

11.12.1 Zhuhai Rundu Pharmaceutical Company Details

11.12.2 Zhuhai Rundu Pharmaceutical Business Overview

11.12.3 Zhuhai Rundu Pharmaceutical Extended-release Medication Introduction

11.12.4 Zhuhai Rundu Pharmaceutical Revenue in Extended-release Medication Business (2020-2025)

11.12.5 Zhuhai Rundu Pharmaceutical Recent Development

11.13 China Res Double-Crane

11.13.1 China Res Double-Crane Company Details

11.13.2 China Res Double-Crane Business Overview

11.13.3 China Res Double-Crane Extended-release Medication Introduction

11.13.4 China Res Double-Crane Revenue in Extended-release Medication Business (2020-2025)

11.13.5 China Res Double-Crane Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

Johnson & Johnson

Takeda

Astrazeneca plc

AbbVie

Pfizer Inc

Collegium Pharmaceutical, Inc.

Endo Pharmaceuticals

Shanghai Shyndec Pharmaceutical

Zhuhai Rundu Pharmaceutical

China Res Double-Crane

Novartis

Sanofi

List of Tables

Table 1. Global Extended-release Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Original Medication

Table 3. Key Players of Generic Medication

Table 4. Global Extended-release Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Extended-release Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Extended-release Medication Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Extended-release Medication Market Share by Region (2020-2025)

Table 8. Global Extended-release Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Extended-release Medication Market Share by Region (2026-2031)

Table 10. Extended-release Medication Market Trends

Table 11. Extended-release Medication Market Drivers

Table 12. Extended-release Medication Market Challenges

Table 13. Extended-release Medication Market Restraints

Table 14. Global Extended-release Medication Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Extended-release Medication Market Share by Players (2020-2025)

Table 16. Global Top Extended-release Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended-release Medication as of 2024)

Table 17. Ranking of Global Top Extended-release Medication Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Extended-release Medication Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Extended-release Medication, Headquarters and Area Served

Table 20. Global Key Players of Extended-release Medication, Product and Application

Table 21. Global Key Players of Extended-release Medication, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Extended-release Medication Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Extended-release Medication Revenue Market Share by Type (2020-2025)

Table 25. Global Extended-release Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Extended-release Medication Revenue Market Share by Type (2026-2031)

Table 27. Global Extended-release Medication Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Extended-release Medication Revenue Market Share by Application (2020-2025)

Table 29. Global Extended-release Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Extended-release Medication Revenue Market Share by Application (2026-2031)

Table 31. North America Extended-release Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Extended-release Medication Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Extended-release Medication Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Extended-release Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Extended-release Medication Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Extended-release Medication Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Extended-release Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Extended-release Medication Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Extended-release Medication Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Extended-release Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Extended-release Medication Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Extended-release Medication Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Extended-release Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Extended-release Medication Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Extended-release Medication Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Extended-release Medication Product

Table 49. Sanofi Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Extended-release Medication Product

Table 54. Novartis Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Bayer Company Details

Table 57. Bayer Business Overview

Table 58. Bayer Extended-release Medication Product

Table 59. Bayer Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 60. Bayer Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Extended-release Medication Product

Table 64. Johnson & Johnson Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. Takeda Company Details

Table 67. Takeda Business Overview

Table 68. Takeda Extended-release Medication Product

Table 69. Takeda Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 70. Takeda Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Extended-release Medication Product

Table 74. AstraZeneca Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. AbbVie Company Details

Table 77. AbbVie Business Overview

Table 78. AbbVie Extended-release Medication Product

Table 79. AbbVie Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 80. AbbVie Recent Development

Table 81. Pfizer Company Details

Table 82. Pfizer Business Overview

Table 83. Pfizer Extended-release Medication Product

Table 84. Pfizer Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 85. Pfizer Recent Development

Table 86. Collegium Pharmaceutical, Inc Company Details

Table 87. Collegium Pharmaceutical, Inc Business Overview

Table 88. Collegium Pharmaceutical, Inc Extended-release Medication Product

Table 89. Collegium Pharmaceutical, Inc Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 90. Collegium Pharmaceutical, Inc Recent Development

Table 91. Endo Pharmaceuticals Company Details

Table 92. Endo Pharmaceuticals Business Overview

Table 93. Endo Pharmaceuticals Extended-release Medication Product

Table 94. Endo Pharmaceuticals Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 95. Endo Pharmaceuticals Recent Development

Table 96. Shanghai Shyndec Pharmaceutical Company Details

Table 97. Shanghai Shyndec Pharmaceutical Business Overview

Table 98. Shanghai Shyndec Pharmaceutical Extended-release Medication Product

Table 99. Shanghai Shyndec Pharmaceutical Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 100. Shanghai Shyndec Pharmaceutical Recent Development

Table 101. Zhuhai Rundu Pharmaceutical Company Details

Table 102. Zhuhai Rundu Pharmaceutical Business Overview

Table 103. Zhuhai Rundu Pharmaceutical Extended-release Medication Product

Table 104. Zhuhai Rundu Pharmaceutical Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 105. Zhuhai Rundu Pharmaceutical Recent Development

Table 106. China Res Double-Crane Company Details

Table 107. China Res Double-Crane Business Overview

Table 108. China Res Double-Crane Extended-release Medication Product

Table 109. China Res Double-Crane Revenue in Extended-release Medication Business (2020-2025) & (US$ Million)

Table 110. China Res Double-Crane Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Extended-release Medication Picture

Figure 2. Global Extended-release Medication Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Extended-release Medication Market Share by Type: 2024 VS 2031

Figure 4. Original Medication Features

Figure 5. Generic Medication Features

Figure 6. Global Extended-release Medication Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Extended-release Medication Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Drugstore Case Studies

Figure 10. Other Case Studies

Figure 11. Extended-release Medication Report Years Considered

Figure 12. Global Extended-release Medication Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Extended-release Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Extended-release Medication Market Share by Region: 2024 VS 2031

Figure 15. Global Extended-release Medication Market Share by Players in 2024

Figure 16. Global Top Extended-release Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended-release Medication as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Extended-release Medication Revenue in 2024

Figure 18. North America Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Extended-release Medication Market Share by Country (2020-2031)

Figure 20. United States Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Extended-release Medication Market Share by Country (2020-2031)

Figure 24. Germany Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Extended-release Medication Market Share by Region (2020-2031)

Figure 32. China Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Extended-release Medication Market Share by Country (2020-2031)

Figure 40. Mexico Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Extended-release Medication Market Share by Country (2020-2031)

Figure 44. Turkey Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Extended-release Medication Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sanofi Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 48. Novartis Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 49. Bayer Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 51. Takeda Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 53. AbbVie Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 55. Collegium Pharmaceutical, Inc Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 56. Endo Pharmaceuticals Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 57. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 58. Zhuhai Rundu Pharmaceutical Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 59. China Res Double-Crane Revenue Growth Rate in Extended-release Medication Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sustained release Medicine Market Research Report 2025

Global Sustained Release Injectables Market Research Report 2024

Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Brand Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Methylphenidate Extended Release Tablets Market Research Report 2024

Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sustained Release Excipients Market Insights Forecast to 2030

Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medications for Chronic Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prescription Pain Medications Market Research Report 2025

Global Sustained Release Coatings Market Insights Forecast to 2030

Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Methylphenidate Hydrochloride Extended Release Tablets Market Research Report 2025

Metformin Hydrochloride Sustained release Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024

Non prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Carbidopa and Levodopa Sustained release Tablets Market Research Report 2024

Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Smart Drug releasing Patches Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions